Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy diversity 6-13 (IGHD6-13) is a gene segment within the immunoglobulin heavy chain locus on human chromosome 14q32[5]. It falls within the "D" (diversity) segment class, which, together with V (variable) and J (joining) gene segments, undergoes somatic rearrangement during B-cell development to create the variable region of the antibody heavy chain, specifically contributing nucleotides to the hypervariable region CDR3[2][3]. This process allows the immune system to generate a vast antibody repertoire using a limited number of inherited gene segments[2][4]. IGHD segments themselves are not functional receptors, proteins, or therapeutic targets; rather, their rearrangement is necessary for the generation of functional immunoglobulin molecules. IGHD6-13 is one of many "D" gene segments, each providing genetic diversity crucial for immune recognition, but not known to be independently associated with specific diseases or targeted by drugs. Key points: - IGHD6-13 is not a standalone therapeutic target or receptor[2][3]. - Errors in naming and duplication in aliases ("DN1, DN1, IGHD613, IGHD6-13") indicate inconsistent use and potential mistakes in database entry[3]. - Its biological significance is limited to its contribution to immunoglobulin gene rearrangement and antibody diversity[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy diversity 6-13 (IGHD6-13).